James S Martin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

James S Martin

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

ACS Omega|April 17, 2023

Design and Synthesis of Covalent Inhibitors of FabAJames S Martin, Claire J Mackenzie, De Lin, et al.

Oncotarget|February 1, 2018

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanomaShujing Liu, Michael T Tetzlaff, Tao Wang, et al.

Nature Communications|December 22, 2018

Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.

Nature Communications|March 13, 2019

Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

ACS Omega|April 17, 2023

Design and Synthesis of Covalent Inhibitors of FabAJames S Martin, Claire J Mackenzie, De Lin, et al.

Oncotarget|February 1, 2018

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanomaShujing Liu, Michael T Tetzlaff, Tao Wang, et al.

Nature Communications|December 22, 2018

Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.

Nature Communications|March 13, 2019

Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesisShujing Liu, Gao Zhang, Jianping Guo, et al.

Pageof 2